Metronidazole therapy for cutaneous leishmaniasis.
A man acquired cutaneous leishmaniasis in Afghanistan. The disease involved two sites and remained active for seven months. Treatment with metronidazole was followed by resolution of the skin lesions in one month.
D000328:Adult; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use*
D008795:Metronidazole